Discovery of HIV capsid inhibitors

Vol 2, 2022 - 153029
Poster
Favorite this paper
How to cite this paper?
Abstract

HIV capsid is formed by a single viral protein (CA), which plays an essential role in early as well as later steps of infection [1]. The correct capsid assembly is essential for HIV infectivity [2]. The high conservation of the aminoacidic sequence of CA and its high sensitivity to mutations highlights its role in the viral cycle success and supports the research of molecules able to interfere with CA multimerization as possible HIV inhibitors [3]. In this work we studied 84 compounds selected through a massive virtual screening of molecules capable of interacting with a conserved region of the interface surface between CA monomers. We analyzed the in vitro assembly of recombinant CA in the presence of these compounds, identifying 30 molecules affecting its multimerization. Additionally, using an in cellulo HIV infection model, we identified 4 compounds interfering with viral infection with IC50 values between 3 and 13 µM.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidad de la República, CENUR Litoral Norte, Departamento de Ciencias Biológicas, Laboratorio de I+D de Moléculas Bioactivas,
Track
  • 1. Strategies in Drug Design
Keywords
imaging learning
HIV
Capsid protein
antiviral drug discovery